يعرض 861 - 880 نتائج من 9,103 نتيجة بحث عن 'significant ((((((gap decrease) OR (step decrease))) OR (we decrease))) OR (mean decrease))', وقت الاستعلام: 0.60s تنقيح النتائج
  1. 861
  2. 862

    Table 2 - حسب Rosanna Mary Rooney (17595801)

    منشور في 2024
    "…<div><p>Background</p><p>Evidence indicates that criminal behaviour in youth is linked with a range of negative physical, mental, and social health consequences. Despite a global decrease over the last 30 years, youth crime remains prevalent. …"
  3. 863

    The RehaGait® system. حسب Johanna Rydja (12300797)

    منشور في 2025
    "…Step height was normalized postoperatively; all other variables remained significantly worse than the HI. …"
  4. 864

    Flow chart of included patients and dropouts. حسب Johanna Rydja (12300797)

    منشور في 2025
    "…Step height was normalized postoperatively; all other variables remained significantly worse than the HI. …"
  5. 865

    Dataset of the analyzed data. حسب Johanna Rydja (12300797)

    منشور في 2025
    "…Step height was normalized postoperatively; all other variables remained significantly worse than the HI. …"
  6. 866
  7. 867

    Table_1_FMT intervention decreases urine 5-HIAA levels: a randomized double-blind controlled study.DOCX حسب Lihong Wang (14991)

    منشور في 2024
    "…However, in the placebo group, GSRS, CARS, and SRS scores showed no significant changes, while ABC scores decreased from 72 to 58.75 (p = 0.034). …"
  8. 868
  9. 869
  10. 870
  11. 871
  12. 872
  13. 873

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. We hypothesize that the addition of ruxolitinib to UCB-Tregs may improve SLE outcomes.…"
  14. 874

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. We hypothesize that the addition of ruxolitinib to UCB-Tregs may improve SLE outcomes.…"
  15. 875

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. We hypothesize that the addition of ruxolitinib to UCB-Tregs may improve SLE outcomes.…"
  16. 876
  17. 877
  18. 878

    Data from: <b>Selection and genetic variation in plasticity drive age-related decreases in among-individual behavioural correlations</b> حسب Chang Seok Han (21814121)

    منشور في 2025
    "…Our findings indicate that the magnitudes of both the positive among-individual and genetic correlations were maintained across nymph and young adult stages, but significantly decreased with age during adulthood. This decrease was due to both selection and genetic variation in age-related behavioural plasticity. …"
  19. 879
  20. 880